Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Nammi Therapeutics Inc
Nammi Therapeutics Inc
OncoC4, Inc.
Compass Therapeutics
Sotio Biotech Inc.
National Cancer Institute (NCI)
ViroMissile, Inc.
Seagen Inc.
SEED Therapeutics, Inc.
Jonsson Comprehensive Cancer Center
MacroGenics
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Degron Therapeutics Co.
NeoTX Therapeutics Ltd.
West China Hospital
Incyte Corporation
Pfizer
GONGCHU Biotechnology Co., Ltd
Exelixis
Jonsson Comprehensive Cancer Center
University of Virginia
Incyte Corporation
Incyte Corporation
HC Biopharma Inc.
Carisma Therapeutics Inc
Vincerx Pharma, Inc.
Molecular Templates, Inc.
Xencor, Inc.
Pliant Therapeutics, Inc.
National Cancer Institute (NCI)
BioEclipse Therapeutics
Atreca, Inc.
University of Florida
Fate Therapeutics
Fate Therapeutics
Xencor, Inc.
Xencor, Inc.
AbbVie
Pfizer
AbbVie
Incyte Corporation
Eli Lilly and Company
Incyte Corporation
Abramson Cancer Center at Penn Medicine
Inovio Pharmaceuticals
AbbVie
Roswell Park Cancer Institute
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Rutgers, The State University of New Jersey